Missed the event? View the presentations from Science Europe’s open science conference.
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
A recent analysis of randomised controlled vaccine trials suggests there are still improvements to be made.
Learn all about the new WHO data sharing policy and their practical guidance on data sharing plans.
A recent study revealed that many researchers fail to comply with their data sharing statement.
An open letter on open access: call for greater clarity and transparency of open access terms and conditions
Learn about the next step in the Plan S drive for open science – a letter to publishers calling for greater transparency on open access policies and contracts.
Dr Tony Ross-Hellauer (ON-MERRITT) discusses how the move toward open research may exacerbate inequity and suggests strategies to prevent it.
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
Springer Nature’s Chief Publishing Officer provides an insight into the transition to open access publishing following their publication of 1 million open access articles.
Find out more about what was covered at this year’s online conference of the Open Access Scholarly Publishing Association (OASPA).
Open access publishing seeks to improve equity, but article processing charges may have the opposite effect
A recent study found that authors with certain characteristics are more likely to publish open access, potentially leading to bias.
We’ve heard of open data, but should we also consider open methods as standard?
Universal access to scientific knowledge: UNESCO outlines the scope of its Recommendation on Open Science
Find out more about the proposed policies and progress towards their adoption.
Find out how COVID-19 has benefited data sharing and what your organisation can do to advance open science from the State of Open Data 2020 report.
Find out more about the case for open access presented by Open Pharma.
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.